Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs — Six Sites, 2005–2016

  • Jackson K
  • Bohm M
  • Brooks J
  • et al.
113Citations
Citations of this article
104Readers
Mendeley users who have this article in their library.

Abstract

© 2018, Department of Health and Human Services. All rights reserved. What is already known about this topic? The ongoing opioid epidemic is associated with increases in human immunodeficiency virus and hepatitis C infections and infection syndromes such as endocarditis. What is added by this report? Persons who inject drugs were an estimated 16.3 times more likely to develop invasive methicillin-resistant Staphylococcus aureus (MRSA) infections than others. Invasive MRSA from injecting drugs increased from 4.1% of invasive MRSA cases to 9.2% (2011–2016). What are the implications for public health practice? Increases in nonsterile injection drug use can cause increases in MRSA infections, underscoring the importance of public health interventions, including prevention of opioid misuse, providing medication-assisted treatment, syringe services programs, and education on safer injection practices to prevent infections from skin flora.

Cite

CITATION STYLE

APA

Jackson, K. A., Bohm, M. K., Brooks, J. T., Asher, A., Nadle, J., Bamberg, W. M., … See, I. (2018). Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs — Six Sites, 2005–2016. MMWR. Morbidity and Mortality Weekly Report, 67(22), 625–628. https://doi.org/10.15585/mmwr.mm6722a2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free